Denator Raises $2.2M in Financing Round | GenomeWeb

This story originally ran on Oct. 21.

Swedish sample prep firm Denator this week said it has completed its fourth financing round, raising 15 million SEK ($2.2 million).

The proceeds are expected to be sufficient to reach positive cash flow and will be used to "continue building Denator's position in the global protein research market," the Gothenburg-based company said in a statement. More specifically, the money will be used to develop Denator's product line and research activities and to expand the firm's sales and marketing activities.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.